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Etiological diagnosis of diarrheal diseases may be complicated by their multi-factorial
nature. In addition, Escherichia coli strains present in the gut can occasionally harbor
virulence genes (VGs) without causing disease, which complicates the assessment
of their clinical significance in particular. The aim of this study was to detect and
quantify nine VGs (stx1, stx2, eae, aggR, ehxA, invA, est,elt and bfpA) typically present
in five E. coli enteric pathotypes [enterohaemorrhagic E. coli (EHEC), enterotoxigenic
E. coli (ETEC), enteropathogenic E. coli (EPEC), enteroaggregative E. coli (EAEC), and
enteroinvasive E. coli (EIEC)] in fecal samples collected from 49 patients with acute
diarrhea and 32 healthy controls from Madrid, Spain. In addition, the presence of four
serotype-related genes (wzxO104 and fliCH4, rfbO157, and fliCH7) was also determined.
Presence of target genes was assessed using a quantitative real-time PCR assay
previously developed, and the association of presence and burden of VGs with clinical
disease and/or other risk factors was explored. Prevalence of ehxA [typically associated
with Shigatoxin producing E. coli (STEC) and (EPEC), invA (EIEC), and the rfbO157+fliCH7
(STEC)] combination were significantly (p < 0.02) higher in the diarrheic group, while the
wzxO104+fliCH4 combination was significantly (p = 0.014) more prevalent in the control
group. On the other hand, eae was detected in more than 90% of the individuals in
both patient and control populations, and it was not associated with bfpA, suggesting
the absence of typical EPEC. No significant differences in the quantitative values were
detected for any VG among study groups, but the difference in the load of aggR (EAEC)
and invA in the patients with respect to the controls was close to the significance,
suggesting a potential role of these VGs in the clinical signs observed when they are
present at high levels.
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INTRODUCTION
Escherichia coli are commensal bacteria living in the intestinal
tract of animals and humans. Some innocuous strains can
incorporate virulence genes (VGs) by lateral gene transfer that
may allow them to cause intestinal and extraintestinal disease
(Ochman et al., 2000). There are six pathotypes than can produce
intestinal disease in humans: STEC (Shigatoxin-producing
E. coli, including EHEC – enterohaemorrhagic E. coli), EPEC
(Enteropathogenic E. coli), ETEC (Enterotoxigenic E. coli), EIEC
(Enteroinvasive E. coli), EAEC (Enteroaggregative E. coli), and
DAEC (Diffusely adherent E. coli; Kaper, 2005). E. coli
strains are classified into these pathotypes depending on the
presence/absence of several combinations of VGs. In EPEC, the
virulence machinery is based on the carriage of eae, tir, and other
proteins required for causing attachment and effacement (A/E)
lesions and they are encoded on a chromosomal pathogenicity
island known as the locus for enterocyte effacement (LEE; Kaper
et al., 2004). Typical EPEC (tEPEC) strains also possess the EAF
plasmid, which encodes for the bundle-forming pili (bfpA gene)
and the perABC genes that regulate eae expression. Atypical
EPEC (aEPEC) strains lack the EAF plasmid (Johnson and
Nolan, 2009), and can affect children in both developed and
developing countries, and together with EHEC and EAEC strains,
are considered an emerging pathogen (Trabulsi et al., 2002;
Huang et al., 2004). EAEC strains possess a pAA plasmid for
fimbriae production, which contains the aggR transcriptional
activator and its regulated genes (Kaper et al., 2004; Johnson
and Nolan, 2009). In addition, there is a cluster of atypical
EAEC strains that lacks aggR and may not produce diarrhea in
humans. EHEC infection can lead to hemorrhagic colitis (HC)
and in the most severe cases hemolytic-uremic syndrome (HUS;
Paton and Paton, 1998), which is often associated with serotypes
O157:H7 and, recently, O104:H4. Their virulence is mainly due
to two types of Shiga-like toxins, Stx1 and Stx2, but also to
eae (intimin) and ehxA (enterohaemolysin). EIEC carries an
invasion plasmid (pInv) which encodes the vir regulon, which
is key for intestinal dysentery. ETEC has been reported as well
as the causative agent of the traveler’s diarrhea in patients who
traveled to developing countries (Gascon et al., 1998). ETEC
pathogenicity is mainly determined by the production of heat-
stable (ST) and labile-stable (LT) enterotoxins. In patients with
an EIEC or ETEC infection, symptoms usually can be resolved
without any complication while in severe cases of EHEC, 10% of
the patients can develop HUS (Nataro and Kaper, 1998). New
pathotypes may also emerge due to the genetic recombination
of some of these VGs, as demonstrated in the 2011 outbreak
in Germany caused by a new O104:H4 EAEC/EHEC strain that
affected 3,816 people and caused 54 deaths (Frank et al., 2011). In
Spain, only one HUS STEC case and one non-HUS case due to
the infection with the EAEC/EHEC strain were reported (Mora
et al., 2011).
In both developing and developed countries, the causative
agents of diarrhea may vary. In developed countries, diarrhea
caused by E. coli (attributed to EPEC, ETEC, and other
pathotypes) in children accounts for less than 0.4% of the
cases (Fletcher et al., 2013) while the detection rate of
E. coli in adults (>12 years) is even lower. In Spain,
EPEC, STEC, and EAEC are the E. coli pathotypes most
commonly isolated in clinical samples (Blanco et al., 2006).
However, there is limited knowledge about the occurrence
and quantitative burden of E. coli VGs in healthy individuals,
which could help to evaluate results from clinically affected
individuals.
The objective of this study was to evaluate if there were
differences in the presentation and amount of VGs in feces from
patients with diarrhea and a subpopulation of healthy individuals
potentially exposed to certain E. coli pathotypes (veterinary
students and laboratory staff) using a direct quantitative real-
time PCR. Four serotype-related genes associated with the
O157:H7 and O104:H4 serotypes (previously associated with
outbreaks of importance in public health) were also investigated
by qPCR. Additionally, we evaluated the association between
certain individual characteristics and the presence and burden
of VGs in the healthy population to identify factors promoting
exposure.
MATERIALS AND METHODS
Study Population
Feces from a total of 81 individuals from two different
populations were collected. First, 49 samples from individuals
belonging to a clinically affected population (“cases”) were
selected randomly among those received during a 1-month
period at the Ramón y Cajal Hospital (Madrid, Spain) from
patients suffering from acute diarrhea (aqueous to mucoid) of
an unknown origin. Information on the gender and age of
the patients and the origin of the patient (hospitalization area,
emergency room or primary health center) were recovered from
the clinical chart from all but three patients. Samples from 30
female and 16 male patients were included in the study, with
ages ranging from 1 to 94 years old. Thirty-three went to their
Primary Health Center, 10 went directly to the Hospital and 3
were admitted in the Emergency room. None of the patients
had received antimicrobial treatment before their samples were
collected.
The healthy population (“controls”) consisted of 20 veterinary
students at the University Complutense and 12 members of
the VISAVET Health Surveillance Center staff (20 females
and 12 males with ages ranging between 18 and 44 years)
that volunteered to participate in the project. None of them
presented any gastrointestinal symptoms when the samples were
collected. Information on the gender, eating habits, traveling
history, previous intestinal illnesses, and antimicrobial therapy
were collected using a questionnaire (available upon request).
This study was authorized by the Ethics Committee for Clinical
Research from the Hospital Ramon y Cajal (Reference 098/12).
VG Detection
Gene selection was made based on a previous study (Cabal et al.,
2013) so that it included the most representative VGs from the
intestinal pathotypes of E. coli and four genes associated with
relevant serotypes for public health (Supplementary Table S1).
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Three grams of the fecal samples were mixed individually with
3 ml of PBS (1/2 dilution) and homogenized vigorously. Four-
hundred milligrams of the resulting solution were used for DNA
extraction, which was performed using a commercial kit (Qiagen
DNA stool mini kit) according to the manufacturer’s instructions.
Then, the amplification of the targets was performed using a real-
time PCR assay (qPCR) as previously described (Cabal et al.,
2015). Briefly, for detection of VGs, a conventional PCR was
first performed using specific primers (Supplementary Table S2)
for control strains (see below) to obtain specific PCR products,
which were ten-fold diluted in order to generate the standard
curves. For the serotype related genes, 10-fold dilutions of STEC
control strains were performed and further used for building
the standards needed for the qPCR. Then, qPCR analysis of
the clinical samples was carried out using primers and probes
described in Supplementary Tables S1 and S3, and quantification
was achieved using the standard curves generated as explained
below. The final gene copy number per milligram of sample was
estimated taking into account the initial weight of the stool, the
dilution factor and the DNA volume added to the qPCR.
The following E. coli control strains were included in all qPCR
reactions as positive controls and were also used to generate the
standard curves: STEC O157:H7 (strain CNM 2686/03 positive
to stx1, sxt2, eae, and ehxA), a typical EPEC (strain CNM764,
positive to bfpA, and eae), provided by Dr. Silvia Herrera León
(National Center of Microbiology, Institute of Health Carlos III,
Madrid, Spain), ETEC (strain H10407, positive to elt, and est),
one EIEC (strain 1280 positive to invA), and the EAEC/EHEC
outbreak strain (LB226692 positive to aggR and stx2), provided
by Dr. Martina Bielaszewska (Institute of Hygiene, Munster
University, Münster, Germany).
Statistical Analysis
The proportion of positive samples and the quantitative results
for each gene in the case and control groups were compared
using Pearson’s and Fisher’s Exact χ2 tests and Mann–Whitney
tests, respectively. In addition, results of the PCR analysis among
the controls were also compared depending on their individual
characteristics. Calculations were performed using SPSS V20.0
(IBM, Chicago, IL, USA).
RESULTS
Qualitative results obtained in case and control samples are
depicted in Table 1. The most prevalent VGs among patients were
eae (n = 45; 91.8%), aggR (n = 31; 63.3%), and invA (n = 40;
81.6%), while eae (n = 30; 93.8%), and aggR (n = 16; 50%) were
the most commonly found VGs in the controls (Table 1). EhxA
and bfpA were both moderately represented in patients (n = 20;
40.8% and n= 14; 28.6%) and controls (n= 5; 15.6% and n= 10;
31.3%), respectively. Stx1 was infrequent in both groups (n = 2;
4.1% in patients and n = 1; 3.1% in controls). Stx2 was only
detected in controls (n = 1, 3.1%) while est was only found in
patients (n = 1; 2%). Interestingly, the elt gene was not found
in any case or control sample. InvA, ehxA, and the simultaneous
presence of rfbO157 with fliCH7 were significantly more prevalent
(p < 0.05) in the diarrheal patients than in healthy controls,
while the opposite was true for the simultaneous detection of both
wzxO104 and fliCH4 (Table 1).
No significant differences between age or sex and detection
of VGs were detected in any of the two groups. Analysis of the
information collected in the survey of the control population
revealed that a significantly higher proportion of this group
was positive for the rfbO157 gene among those taking antibiotics
in comparison with those who did not (p = 0.01). Marginally
significant differences between the presence of ehxA and the
consumption of antibiotics was also observed (higher in those
taking antibiotics, p = 0.057). Also, proportion of controls
positive to aggR and bfpA was marginally significantly higher
(p = 0.1 and p = 0.08, respectively) among those with travel
history (Table 2). No significant differences in the proportion of
positive samples to any other VG and the variables under study
were detected.
In the quantitative analysis, only VGs that were present in
at least five samples (ehxA, eae, aggR, bfpA, rfbO157, fliCH7,
and fliCH4) were considered (Table 3). Within these analyses,
no significant differences between the quantitative values found
in each group were detected, except for the fliCH4 gene [with
a significantly (p < 0.007) higher number of gene copies per
milligram of sample in the control group]. Marginally significant
differences were found for aggR and invA, present at higher
quantities in the patients (p = 0.07 and 0.084, respectively). In
healthy controls, the maximum gene copy number for a given VG
per milligram of feces was always under 10e+04. In contrast, for
the patients, there was a maximum of 10e+07 gene copy number.
If a tentative cut-off value was established so that patients with
gene copy numbers per milligram of feces >10e+03 (Cabal et al.,
2015) were considered positive for that VG, only four patients
would be positive for VGs from pathogenic E. coli compared to
one control. Those four patients with copy numbers above 10e+03
for at least one VG were positive to eae/aggR/est, aggR/invA,
eae/bfpA, and eae, respectively.
TABLE 1 | Percentage and 95% confidence intervals (CI) of the proportion
of samples positive to each molecular target in patients (cases) and
healthy volunteers (controls).
Molecular target Cases (n = 49) Controls (n = 32) p
stx1 4.1 (1.1−13.7) 3.1 (0.55−15.7) 0.66
stx2 0.0 (0.0−7.27) 3.1 (0.55−15.7) 0.40
eae 91.8 (80.8−96.8) 93.8 (79.9−98.3) 0.56
ehxA 40.8 (28.2−54.8) 15.6 (6.86−31.8) 0.014
elt 0.0 (0.0−7.27) 0 (0.0−10.7) –
est 2.04 (0.36−10.7) 0 (0.0−10.7) 0.61
invA 81.6 (68.6−90.0) 6.25 (1.73−20.1) <0.001
bfpA 28.6 (17.8−42.4) 31.3 (18.0−48.6) 0.49
aggR 63.3 (49.3−75.3) 50.0 (33.6−66.4) 0.17
O157+H7a 53.1 (39.4−66.3) 18.8 (8.89−35.3) 0.002
O104+H4a 2.04 (0.36−10.7) 18.8 (8.89−35.3) 0.014
a Indicates simultaneous detection in a given sample of genes linked to the somatic
and flagellar antigens (rfbO157, fliCH7, and wzxO104, fliCH4).
Significant p-values are highlighted in bold.
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TABLE 2 | Characteristics of the control population and proportion of positive samples to the virulence genes (VGs) for which marginally significant
(p < 0.1) differences were found.
Variable Response N (%) ehxAa rfbO157a bfpAa aggRa
Received antibiotic treatment in the last 3 months Yes 7 (21, 9%) 42, 8% 71, 4%
No 25 (78, 1%) 8% 16%
Foreign travel in the last 3 months Yes 4 (12,5%) 75% 100%
No 28 (87, 5%) 25% 42,8%
Gastrointestinal problems in the last 3 months Yes 11 (34, 4%)
No 21 (65, 6%)
Frequent contact with animals Yes 27 (84, 4%)
No 5 (15, 6%)
Vegetarian Yes 1 (3, 1%)
No 31 (96, 9%)
Regular consumption of probiotics Yes 23 (71, 9%)
No 9 (28, 1%)
aPercentage of positive samples among the controls that were positive to each virulence factor.
TABLE 3 | Quantitative values (median) for VGs present in at least five samples in patients and controls.
Patients Controls p-Value
Gene Median values (n)a Samples > 1.00e+03 (n = 5)b Median values (n)a Samples > 1.00e+03 (n = 5)b
eae 0.82 (45) 4 0.59 (30) 1 0.88
ehxA 0.22 (20) 0 0.24 (5) 0 0.92
aggR 1.41 (31) 2 0.87 (16) 0 0.07
bfpA 1.72 (14) 1 4.56 (10) 0 0.62
invA 43.5 (40) 1 8.04 (2) 0 0.084
rfbO157 0.50 (30) 0 0.84 (9) 0 0.27
fliCH7 1.21 (42) 0 3.06 (16) 0 0.13
fliCH4 182.4 (29) 0 14.760 (23) 0 0.007
aMedian values are expressed in gene copies per milligram of feces. bNumber of positive individuals when gene copy number per milligram of feces is equal or above
1.00e+03.
DISCUSSION
In this study, we estimated the qualitative and quantitative (gene
copy number per milligram of sample) abundance of VGs in the
feces of two groups of individuals, healthy volunteers and patients
with diarrhea. Overall, the prevalence of VGs in both groups was
high. In fact, while the presence of VGs in the feces of patients
with diarrhea was expected to some extent, healthy controls
carried VGs as well (Stephan et al., 2000; Fujihara et al., 2009).
Humans have been proven to act sometimes as mere carriers
of these VGs without being necessarily related with intestinal
disease (Jenkins et al., 2007) since they may need to coexist
with other VGs and eventually in an adequate microorganisms
to produce clinical symptoms (Rosenshine et al., 1996; Barletta
et al., 2011). The high prevalence observed may be due in part
to the analytical approach adopted here, since qPCR-based direct
detection of DNA extracted from fecal samples may yield a
higher analytic sensitivity than isolation of E. coli followed by
PCR-detection.
The aggR gene was observed at high prevalence in both
patients (63.3%) and controls (50%), in contrast with a similar
study by Samie et al. (2007) that described higher prevalence
of aggR in the patient group. However, the higher numbers of
gene copies in positive case samples compared to the controls,
which was close to the statistical significance (Table 3), was in
line with the findings of that study, suggesting that that aggR may
contribute to the patient symptoms (Samie et al., 2007).
The wzxO104/fliCH4 combination, recently associated with
EAEC (Bielaszewska et al., 2011), was more common in healthy
individuals (18.8%) than in patients (2.04%), with most of
these positive control samples being positive also to aggR (4/6
and 66.7%), suggesting asymptomatic carriage of EAEC and/or
EAEC/EHEC as previously reported (Mathewson et al., 1985;
Balabanova et al., 2013).
In contrast, the prevalence and quantities of bfpA, which
may indicate presence of tEPEC, was similar in both patients
and healthy individuals, suggesting a limited pathogenic role
as previously proposed (Wang et al., 2013). Interestingly, the
marginally significant differences found in the controls who
traveled abroad for bfpA but also for aggR may indicate
that EPEC and EAEC are the pathotypes most probably
acquired during international travels, as previously described
(Tangden et al., 2010; Laaveri et al., 2014). Detection of
other tEPEC virulence markers in bfpA-positive samples
could help in elucidating the real role of bfpA in disease
pathogenesis.
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In the case of eae, its large prevalence (>90%) in bfpA-negative
fecal samples could indicate the presence of aEPEC. In addition,
the fact that eae frequencies were similar in both groups was in
agreement with previous studies (Fujihara et al., 2009; Ghosh
and Ali, 2010; Schmidt, 2010), and therefore it also questions its
potential pathogenic role in our study population.
The low prevalence found for stx-genes was in agreement with
that reported by Pradel et al. (2000), which was also similar for
both patients and controls. Still, the high frequencies obtained
for eae, ehxA, and rfbO157/fliCH7 genes (particularly among case
samples) may indicate the presence of O157:H7 strains despite
the low prevalence obtained for the Shiga toxins. It has been
shown that both EPEC and EHEC O157:H7 strains can exist in
patients with HUS or diarrhea (Ferdous et al., 2015), and a whole
genome analysis approach would be needed to differentiate them.
In the case of EIEC, represented in this study by invA, the
high prevalence obtained for patients together with a higher
gene copy number in this group could indicate that invA is
directly related with pathogenicity, thus explaining its absence
(or presence at very low levels) in healthy controls (Labbé and
García, 2013). Bruijnesteijn van Coppenraet et al. (2015) also
found EIEC-typical genes in a significantly higher proportion of
cases compared with a control population, while no differences
were observed for STEC-associated genes.
Lastly, detection rates for est and/or elt, usually associated
with the ETEC pathotype and therefore with Traveler’s diarrhea,
were low among diarrheal patients, although interpretation of
these results is not possible due to the lack of information on
the patient’s travel history (Qadri et al., 2005; Rivera et al., 2013).
Among the variables included in the survey performed in the
control population, we only observed a significant association
between ehxA or rfbO157 and antibiotic intake (Table 2).
A marginally significant association between aggR or bfpA and
foreign travel was seen in agreement with previous reports (Evans
and Evans, 1996; Jiang et al., 2002).
Comparison of results obtained in the case and control
populations obtained here must be performed carefully since,
while cases were sampled randomly among those submitted to
a large hospital in Madrid, our control population was severely
biased toward a very specific subpopulation (veterinary students
and laboratory staff) that could be exposed to certain risks (i.e.,
STEC of animal origin), and may thus not be representative of the
general population. Interestingly, prevalence of VGs associated
with STEC (i.e., stx1, and stx2) was very low in both cases
and controls (Table 1), thus suggesting a non-differential degree
of exposure to sources of this particular pathotype. Another
limitation was the limited size of our sample; even though
matching by age and sex could have helped to increase the power
of the study, this information was not available when controls
were recruited and was thus not possible.
In summary, our strategy allowed the assessment of the
prevalence and abundance of VGs associated with diarrheagenic
E. coli in healthy volunteers and also in patients with diarrhea.
In some cases both groups were carriers of the same VGs,
highlighting the fact that not all VGs might be linked with
pathogenicity or may need additional association with other
VG to produce diarrhea. Moreover, the VG quantification could
help to determine whether a VG is crucial for the onset
of the diarrhea or not and may facilitate the isolation of
positive colonies. Although some individual characteristics were
marginally associated with increased odds of being positive for
certain VGs in the control population, the limited sample size
used here prevents extracting definitive conclusions.
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